Gary Davey, a 68-year-old from Dixon, Illinois, has defied the odds after being diagnosed with metastatic prostate cancer nearly 14 years ago. Initially told he wouldn't see Christmas, Davey has not only lived but thrived, thanks to his participation in clinical trials at the UW Health Carbone Cancer Center in Madison.
A Grim Diagnosis and a Search for Hope
Davey's journey began with a routine blood test that revealed the presence of prostate cancer. Despite undergoing a prostatectomy, the cancer returned a year later, progressing to metastatic prostate cancer, a condition considered incurable. "Gary's cancer was spreading and he had disease in almost every bone in his body," explained Dr. Joshua Lang with UW Health.
Facing limited options, Davey opted for clinical trials at UW Health Carbone Cancer Center, foregoing chemotherapy. One particular trial involved taking multiple pills daily. "I take 4, 5, 6, 7, 8, 9. Nine. Four of them are like this big," Davey described, illustrating the size of some of the pills.
Remarkable Results and a New Lease on Life
The results of the clinical trial have been astounding. Davey's cancer, once widespread, is now undetectable. "We're writing medical history because no one has lived this long," Davey proudly stated. This success has allowed him to enjoy precious moments with his grandchildren and plan for future milestones.
Davey's experience underscores the importance of clinical trials in advancing cancer treatment. According to Dr. Lang, the newer class of drugs Davey has been taking is now FDA-approved across the world. "Gary is a true inspiration. One, being part of this trial, not only to help himself, but to help others fighting this disease. Because of what he has done... hundreds, thousands of men now have access to treatment because of the clinical trial Gary was part of," Lang said.
The Importance of Early Detection and Continued Treatment
Despite his undetectable status, Davey remains on treatment and visits Madison monthly for check-ups. He emphasizes the importance of regular PSA testing for early detection of prostate cancer. Health experts recommend men begin screening around age 55, or earlier depending on their risk factors.
While metastatic cancer is not curable, Davey's story highlights the potential for long-term management and improved quality of life through innovative treatments and clinical trials. His journey serves as a beacon of hope for others facing similar diagnoses.
